These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29692979)

  • 1. An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study.
    Gupta SK; Kumar KD
    Int J Pharm Investig; 2017; 7(4):193-197. PubMed ID: 29692979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.
    More SA; Atal S; Mishra PS
    J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions.
    Shukla AK; Jhaj R; Misra S; Ahmed SN; Nanda M; Chaudhary D
    J Family Med Prim Care; 2021 Sep; 10(9):3303-3308. PubMed ID: 34760748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
    Belhekar MN; Taur SR; Munshi RP
    Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
    Pandit S; Soni D; Krishnamurthy B; Belhekar MN
    J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
    Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
    PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool.
    Leopoldino RWD; de Oliveira LVS; Fernandes FEM; de Lima Costa HTM; Vale LMP; Oliveira AG; Martins RR
    Int J Clin Pharm; 2023 Aug; 45(4):1007-1013. PubMed ID: 37212967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.
    Théophile H; André M; Miremont-Salamé G; Arimone Y; Bégaud B
    Drug Saf; 2013 Oct; 36(10):1033-44. PubMed ID: 23828659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study.
    Um SH; Abuzgaia A; Rieder M
    Br J Clin Pharmacol; 2023 Aug; 89(8):2407-2412. PubMed ID: 36849649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
    Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
    Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.
    Beniwal R; Gupta LK; Khare AK; Mittal A; Mehta S; Balai M
    Indian Dermatol Online J; 2019; 10(1):27-33. PubMed ID: 30775295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.
    Kane-Gill SL; Forsberg EA; Verrico MM; Handler SM
    Drug Saf; 2012 Aug; 35(8):645-53. PubMed ID: 22720659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Pattern and Causality Assessment of Drug-induced Cutaneous Reactions in a Tertiary Care Hospital in India: A Prospective Study.
    James J; Mohamed AB; Hussain FS; Rani J; Varadarajan S
    Curr Drug Saf; 2022; 17(3):193-198. PubMed ID: 34702154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.
    Goldman JL; Chung WH; Lee BR; Chen CB; Lu CW; Hoetzenecker W; Micheletti R; Yasuda SU; Margolis DJ; Shear NH; Struewing JP; Pirmohamed M
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1135-1141. PubMed ID: 30918988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review.
    Manjhi PK; Singh MP; Kumar M
    Cureus; 2024 May; 16(5):e59975. PubMed ID: 38854273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India.
    Sharma A; Kumari KM; Manohar HD; Bairy KL; Thomas J
    Perspect Clin Res; 2015; 6(2):109-15. PubMed ID: 25878957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children.
    Tantikul C; Dhana N; Jongjarearnprasert K; Visitsunthorn N; Vichyanond P; Jirapongsananuruk O
    Asian Pac J Allergy Immunol; 2008; 26(2-3):77-82. PubMed ID: 19054924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causality assessment of adverse drug reactions by applying a global introspection method in a high complexity hospital.
    Rezende de Menezes R; Graciano Silva MDD; Pinho Ribeiro AL; Martins Pinto Filho M; Martinho GH; Carvalho Ferreira LE; Parreiras Martins MA
    Explor Res Clin Soc Pharm; 2021 Sep; 3():100064. PubMed ID: 35480605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.